Thesis

Co-design and development of a Dosage and Intensity Monitor (DAIM) for stroke rehabilitation

Creator
Rights statement
Awarding institution
  • University of Strathclyde
Date of award
  • 2026
Thesis identifier
  • T17658
Person Identifier (Local)
  • 202150407
Qualification Level
Qualification Name
Department, School or Faculty
Abstract
  • Rehabilitation is essential for regaining motor, cognitive, and functional abilities followingstroke. Recent updates to the National Clinical Guidelines for Stroke in the UK and Irelandnow recommend a minimum of three hours of daily multidisciplinary therapy, a fourfoldincrease from the previous 45-minutes. Accurately measuring the true delivery of rehabilitationdosage and intensity, however, remains a critical challenge. Commonly, clinical trials describetheir control groups as "standard physiotherapy," but fail to detail accurately what this entails.Without accurate measurement techniques, it is impossible to ensure guideline adherence,correctly interpret research outcomes, or meaningfully compare new interventions againstexisting practices.This thesis presents the co-design, development, and evaluation of a Dosage and IntensityMonitor (DAIM), a digital system specifically created to objectively quantify rehabilitationdosage and intensity in stroke survivors across home, research, and clinical environments. Builtthrough a user-centred design framework aligned with Medical Research Council (MRC)guidance for complex interventions, the thesis employed focus groups, iterative prototyping,stakeholder feedback, and survey-based validation to ensure the system was relevant, usable,and grounded in real-world rehabilitation needs.The final DAIM system integrates a wearable movement sensor and NFC tagging with a user-friendly mobile application, accurately capturing rehabilitation activities such as walking,cycling and sit-to-stand. Real-time feedback, gamified goal setting, and group-based progresstracking were embedded to promote motivation, engagement, and adherence to rehabilitation.Software prototypes, developed through collaborative design methods and Android Studioprototyping, ensured optimal accessibility and usability, particularly for users with stroke-related cognitive or motor impairments.Validation testing in both clinical and research settings demonstrated that the DAIM providedhighly accurate (96% agreement with optical tracking) data with a user friendly system (100%user success) that agreed (1.23 min difference, on average) with clinician-recorded data. Thissystem, therefore, addresses the critical gap in objectively measuring rehabilitation dosage andintensity, offering a robust solution for both clinical practice and research applications. Futurework should focus on optimising hardware ergonomics, producing a market ready system andscaling up usability testing.
Advisor / supervisor
  • Kerr, Andrew, Ph. D.
  • Dunlop, Mark
Resource Type
DOI
Date Created
  • 2025

Relations

Items